$2.24+0.01 (+0.45%)
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
China SXT Pharmaceuticals, Inc. in the Healthcare sector is trading at $2.24 with a market capitalization of $24,296. The stock is currently near its 52-week low of $2.06, remaining 99.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 13 is oversold, raising the odds of a near-term bounce. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Total Revenue | β | β | β | β | β |
| Gross Profit | β | β | β | β | β |
| Operating Income | β | β | β | β | β |
| Net Income | β | β | β | β | β |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, an...